Cargando…
Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients
BACKGROUND: The cause of multiple sclerosis (MS) is currently unknown, but it is thought that oxidative damage and iron metabolism mechanisms are involved. The aim of this study was to examine ceruloplasmin concentration in MS patients based on various immunomodifying therapies and to test the effec...
Autores principales: | Adamczyk-Sowa, Monika, Sowa, Paweł, Mucha, Sebastian, Zostawa, Jacek, Mazur, Bogdan, Owczarek, Maciej, Pierzchała, Krystyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958372/ https://www.ncbi.nlm.nih.gov/pubmed/27420299 http://dx.doi.org/10.12659/MSM.895702 |
Ejemplares similares
-
The influence of sodium on pathophysiology of multiple sclerosis
por: Zostawa, Jacek, et al.
Publicado: (2017) -
Melatonin Acts as Antioxidant and Improves Sleep in MS Patients
por: Adamczyk-Sowa, Monika, et al.
Publicado: (2014) -
Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches
por: Niedziela, Natalia, et al.
Publicado: (2016) -
Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment
por: Adamczyk-Sowa, Monika, et al.
Publicado: (2017) -
Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D(3)
por: Niedziela, Natalia, et al.
Publicado: (2018)